Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Bonté PE"'
Autor:
Huet, C., Basse, C., Knetki-Wroblewska, M., Chilczuk, P., Bonte, PE., Cyrille, S., Gobbini, E., Du Rusquec, P., Olszyna-Serementa, M., Daniel, C., Lucibello, F., Lahmi, L., Krzakowski, M., Girard, N.
Publikováno v:
In Clinical Lung Cancer July 2024
Autor:
Bonnin E; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Rodrigo Riestra M; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Marziali F; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Mena Osuna R; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Denizeau J; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Maurin M; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Saez JJ; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Jouve M; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Bonté PE; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Richer W; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Nevo F; Egle Therapeutics, Paris, France., Lemoine S; Egle Therapeutics, Paris, France., Girard N; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Paris Saclay University, UVSQ, Versailles, France.; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France., Lefevre M; Pathology Department, Institut Mutualiste Montsouris, Paris, France., Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Vincent-Salomon A; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France.; Diagnostic and Theranostic Medicine Division, Institut Curie, PSL Research University, Paris, France., Baulande S; Institut Curie Genomics of Excellence (ICGex) Platform, PSL Research University, Institut Curie Research Center, Paris, France., Moreau HD; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Sedlik C; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Hivroz C; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Lennon-Duménil AM; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Tosello Boari J; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France. jimena.tosello@curie.fr.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France. jimena.tosello@curie.fr., Piaggio E; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France. eliane.piaggio@curie.fr.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France. eliane.piaggio@curie.fr.; Egle Therapeutics, Paris, France. eliane.piaggio@curie.fr.
Publikováno v:
Nature communications [Nat Commun] 2024 May 03; Vol. 15 (1), pp. 3749. Date of Electronic Publication: 2024 May 03.
Autor:
Bagley SJ; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. sbagley@pennmedicine.upenn.edu., Binder ZA; Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; GBM Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Lamrani L; Clinical Immunology Laboratory, Institut Curie, Paris, France.; INSERM U932, PSL University, Immunity and Cancer, Institut Curie Research Center, Paris, France.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Marinari E; Agora Cancer Research Center, Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Lausanne and Geneva, Geneva, Switzerland.; Department of Oncology, University Hospital of Geneva, Geneva, Switzerland., Desai AS; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Nasrallah MP; GBM Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Maloney E; Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Brem S; Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; GBM Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Lustig RA; Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Kurtz G; Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Alonso-Basanta M; Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Bonté PE; INSERM U932, PSL University, Immunity and Cancer, Institut Curie Research Center, Paris, France., Goudot C; INSERM U932, PSL University, Immunity and Cancer, Institut Curie Research Center, Paris, France., Richer W; INSERM U932, PSL University, Immunity and Cancer, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Piaggio E; INSERM U932, PSL University, Immunity and Cancer, Institut Curie Research Center, Paris, France., Kothari S; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA., Guyonnet L; Cytometry Platform, CurieCoreTech, Institut Curie, Paris, France., Guerin CL; Cytometry Platform, CurieCoreTech, Institut Curie, Paris, France., Waterfall JJ; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.; INSERM U830, PSL University, Institut Curie Research Cente, Paris, France., Mohan S; Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Hwang WT; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Tang OY; GBM Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Warren Alpert Medical School of Brown University, Providence, RI, USA., Logun M; Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; GBM Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Bhattacharyya M; GBM Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Cooper Medical School of Rowan University, Camden, NJ, USA., Markowitz K; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Delman D; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Marshall A; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Wherry EJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Institute for Immunology and Immune Health, Cambridge, MA, USA., Amigorena S; INSERM U932, PSL University, Immunity and Cancer, Institut Curie Research Center, Paris, France., Beatty GL; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; GBM Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Brogdon JL; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Hexner E; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Migliorini D; Agora Cancer Research Center, Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Lausanne and Geneva, Geneva, Switzerland.; Department of Oncology, University Hospital of Geneva, Geneva, Switzerland., Alanio C; Clinical Immunology Laboratory, Institut Curie, Paris, France. cecile.alanio@curie.fr.; INSERM U932, PSL University, Immunity and Cancer, Institut Curie Research Center, Paris, France. cecile.alanio@curie.fr.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. cecile.alanio@curie.fr., O'Rourke DM; Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; GBM Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Nature cancer [Nat Cancer] 2024 Mar; Vol. 5 (3), pp. 517-531. Date of Electronic Publication: 2024 Jan 12.
Autor:
López-Cobo S; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France., Fuentealba JR; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France., Gueguen P; Department of Oncology, UNIL CHUV and Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Bonté PE; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France., Tsalkitzi K; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.; Mnemo Therapeutics, Paris, France., Chacón I; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France., Glauzy S; Institut Curie, PSL Research University, Sorbonne Université, CNRS, UMR 144, Paris, France., Bohineust A; Mnemo Therapeutics, Paris, France., Biquand A; Mnemo Therapeutics, Paris, France., Silva L; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France., Gouveia Z; Institut Curie, PSL Research University, Sorbonne Université, CNRS, UMR 144, Paris, France., Goudot C; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France., Perez F; Institut Curie, PSL Research University, Sorbonne Université, CNRS, UMR 144, Paris, France., Saitakis M; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.; Mnemo Therapeutics, Paris, France., Amigorena S; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.; Mnemo Therapeutics, Paris, France.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Jan 12; Vol. 14 (1), pp. 120-141.
Autor:
Bonté PE; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Metoikidou C; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Heurtebise-Chretien S; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Arribas YA; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Sutra Del Galy A; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Ye M; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Niborski LL; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Zueva E; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Piaggio E; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Seguin-Givelet A; Institut Mutualiste Montsouris, Paris 75014, France., Girard N; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France.; Institut Curie, Institut du Thorax Curie Montsouris, Paris 75005, France.; Paris Saclay, UVSQ, UFR Simmone Veil, Versailles 78000, France., Alanio C; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France.; Laboratoire d'immunologie clinique, Institut Curie, Paris 75005, France.; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA., Burbage M; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Goudot C; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France., Amigorena S; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris 75005, France.
Publikováno v:
Science immunology [Sci Immunol] 2023 Oct 27; Vol. 8 (88), pp. eadf8838. Date of Electronic Publication: 2023 Oct 27.
Autor:
Basse C; Thoracic Oncology, Institut Curie, Paris-St Cloud, France; University of Versailles Saint Quentin, Faculté de médecine Simone-Veil, Paris Saclay University, Versailles, France., Ancel J; Pneumology Department, Reims Hospital, France., Massiani MA; Thoracic Oncology, Institut Curie, Paris-St Cloud, France., Bonté PE; Biostatistics Department, Research Center, Institut Curie, Paris, France., Beaulaton C; Pathology Department, Institut Curie, Paris, France., Beaucaire-Danel S; Thoracic Oncology, Institut Curie, Paris-St Cloud, France., Milder M; Data Department, Institut Curie, Paris, France., Cao K; Radiation Department, Institut Curie, Paris, France., Daniel C; Thoracic Oncology, Institut Curie, Paris-St Cloud, France., Du Rusquec P; Thoracic Oncology, Institut Curie, Paris-St Cloud, France., Sablin MP; Medical Oncology Department, Institut Curie, Paris, France., Kirova Y; Radiation Department, Institut Curie, Paris, France., Sage E; University of Versailles Saint Quentin, Faculté de médecine Simone-Veil, Paris Saclay University, Versailles, France; Thoracic Surgery Department, Hôpital Foch, Suresnes, France., Beddok A; Radiation Department, Institut Curie, Paris, France., Girard N; Thoracic Oncology, Institut Curie, Paris-St Cloud, France; University of Versailles Saint Quentin, Faculté de médecine Simone-Veil, Paris Saclay University, Versailles, France. Electronic address: nicolas.girard2@curie.fr.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Aug; Vol. 182, pp. 107295. Date of Electronic Publication: 2023 Jul 11.
Autor:
Naghavian R; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.; Cellerys AG, Schlieren, Switzerland., Faigle W; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.; Cellerys AG, Schlieren, Switzerland.; Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France., Oldrati P; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland., Wang J; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.; School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China., Toussaint NC; NEXUS Personalized Health Technologies, ETH Zurich, Schlieren, Switzerland.; Swiss Institute of Bioinformatics, Zurich, Switzerland., Qiu Y; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland., Medici G; Clinical Neuroscience Center, Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Wacker M; Department of Peptide-based Immunotherapy, University of Tübingen, University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Freudenmann LK; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Bonté PE; Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France., Weller M; Laboratory of Molecular Neuro-Oncology, Department of Neurology and Clinical Neuroscience, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Regli L; Clinical Neuroscience Center, Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Amigorena S; Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France., Rammensee HG; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Walz JS; Department of Peptide-based Immunotherapy, University of Tübingen, University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Brugger SD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Mohme M; Department of Neurosurgery, University Hospital Hamburg Eppendorf, University of Hamburg, Hamburg, Germany., Zhao Y; Computational and Systems Biology Branch, Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA., Sospedra M; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.; Cellerys AG, Schlieren, Switzerland., Neidert MC; Clinical Neuroscience Center, Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Neurosurgery, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Martin R; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland. roland.martin@uzh.ch.; Cellerys AG, Schlieren, Switzerland. roland.martin@uzh.ch.; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. roland.martin@uzh.ch.; Therapeutic Immune Design Unit, Center for Molecular Medicine, Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden. roland.martin@uzh.ch.
Publikováno v:
Nature [Nature] 2023 May; Vol. 617 (7962), pp. 807-817. Date of Electronic Publication: 2023 May 17.
Autor:
Brouiller F; Institut Curie, PSL∗ Research University, INSERM U 932, 75005 Paris, France., Nadalin F; Institut Curie, PSL∗ Research University, INSERM U 932, 75005 Paris, France., Bonté PE; Institut Curie, PSL∗ Research University, INSERM U 932, 75005 Paris, France., Ait-Mohamed O; Institut Curie, PSL∗ Research University, INSERM U 932, 75005 Paris, France., Delaugerre C; Laboratoire de Virologie, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; INSERM U944, Université de Paris, Paris, France., Lelièvre JD; Vaccine Research Institute, Institut National de la Santé et de la Recherche médicale (INSERM), Assistance Publique Hôpitaux de Paris (APHP), Hôpital H. Mondor, Créteil, France., Ginhoux F; Singapore Immunology Network (SIgN), A∗STAR, 8A Biomedical Grove, Immunos Building, Level 4, Singapore 138648, Singapore.; Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.; Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore 169856, Singapore., Ruffin N; Institut Curie, PSL∗ Research University, INSERM U 932, 75005 Paris, France., Benaroch P; Institut Curie, PSL∗ Research University, INSERM U 932, 75005 Paris, France.
Publikováno v:
IScience [iScience] 2023 Jan 20; Vol. 26 (2), pp. 106019. Date of Electronic Publication: 2023 Jan 20 (Print Publication: 2023).
Autor:
Bonté PE; Institut Curie, PSL University, INSERM U932, Immunity and Cancer, 75005 Paris, France., Arribas YA; Institut Curie, PSL University, INSERM U932, Immunity and Cancer, 75005 Paris, France., Merlotti A; Institut Curie, PSL University, INSERM U932, Immunity and Cancer, 75005 Paris, France., Carrascal M; Biological and Environmental Proteomics, Institut d'Investigacions Biomèdiques de Barcelona-CSIC, IDIBAPS, Roselló 161, 6a planta, 08036 Barcelona, Spain., Zhang JV; GBM Translational Center of Excellence, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Zueva E; Institut Curie, PSL University, INSERM U932, Immunity and Cancer, 75005 Paris, France., Binder ZA; GBM Translational Center of Excellence, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Alanio C; Institut Curie, PSL University, INSERM U932, Immunity and Cancer, 75005 Paris, France; Laboratoire d'Immunologie Clinique, Institut Curie, Paris 75005, France; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA., Goudot C; Institut Curie, PSL University, INSERM U932, Immunity and Cancer, 75005 Paris, France. Electronic address: christel.goudot@curie.fr., Amigorena S; Institut Curie, PSL University, INSERM U932, Immunity and Cancer, 75005 Paris, France. Electronic address: sebastian.amigorena@curie.fr.
Publikováno v:
Cell reports [Cell Rep] 2022 Jun 07; Vol. 39 (10), pp. 110916.
Autor:
Li, Zhuocheng1 (AUTHOR), Jian, Chenxi1 (AUTHOR), Li, Yuanyuan2 (AUTHOR), Pan, Zhenyu3 (AUTHOR), Yang, Guozi3 (AUTHOR), Sun, Xingru3 (AUTHOR) 18843108845@163.com
Publikováno v:
BMC Cancer. 10/8/2024, Vol. 24 Issue 1, p1-8. 8p.